CompletedPhase 3

Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients

Spain31 participantsStarted 2012-08

Plain-language summary

Use of Paricalcitol in stage Vd Chronic Kidney Disease patients, over the effect of inflammatory and oxidative stress parameters.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Vd CKD patients using haemodialysis during 3 or more months. * Tunnelized-bearer permanent catheters on haemodialysis at last 6 months previous at the beginning of the study. . * Kt stable, over 45 litres on both sexs. * Patients in treatment wiht atorvastatin * Patients without infectious or inflammatory processes over 8 weeks. * Two consecutive PTH \< than 400 pg/ml; Ca\<10.2 and P \<7.0 mg/dl. Exclusion Criteria: * Patients \> 18 years. * Pregnant women. * Patients hospitalized 4 weeks before the beginning of the treatment. * Immunosuppressor intake.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Oxidative stress and inflammative parameters in patients wiht CKD stage Vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment wiht visits and analysis

Oxidative stress and inflammative parameters

Timeframe: 12 weeks of treatment

Oxidative stress and inflammative parameters in patients with CKD stage vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment with visits and analysis

Oxidative stress and inflammative parameters in patients with CKD stage vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment with visits and analysis

Oxidative stress and inflammative parameters in patients with CKD stage vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment with visits and analysis

Oxidative stress and inflammative parameters in patients with CKD stage vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment with visits and analysis

Trial details

NCT IDNCT01820767

SponsorRicardo Mouzo Mirco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-10

View on ClinicalTrials.gov More Chronic Kidney Disease trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Oxidative stress and inflammative parameters in patients wiht CKD stage Vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment wiht visits and analysis

Oxidative stress and inflammative parameters

Timeframe: 12 weeks of treatment

Oxidative stress and inflammative parameters in patients with CKD stage vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment with visits and analysis

Oxidative stress and inflammative parameters in patients with CKD stage vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment with visits and analysis

Oxidative stress and inflammative parameters in patients with CKD stage vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment with visits and analysis

Oxidative stress and inflammative parameters in patients with CKD stage vitamin D after 12 weeks of treatment

Timeframe: 12 weeks of treatment with visits and analysis